Transarterial chemoembolization with rivoceranib and camrelizumab for BCLC stage C hepatocellular carcinoma.

Front Oncol · 2025 · PMC12727550 · PMID 41450929

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although PFS improvement did not reach statistical significance in the single-tumor subgroup, the P value of 0.095 also had the tendency of significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.